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CONCLUSIONS
There is good agreement between SUVR measures on a PET-MR scanner across different 
choices of region, reference regions, and attenuation correction methods. Rates of amyloid 
positivity for this age group are consistent with recent meta-analyses[8]. Participants in this 
substudy will also soon begin to have longitudinal follow up with PET-MR, which will further 
help assess these pipelines.
RESULTS
240 participants with suitable T1 and amyloid PET data were included. For
cortical ROIs, the mixture model typically produced two clusters, confirming
the expected bimodal distribution of amyloid deposition. Across the
different reference regions, amyloid positive individuals were consistently
15-18% without PVC correction and 19-23% with PVC correction (Table).
The precuneus and posterior cingulate ROIs, regions often implicated early
in AD, had slightly more amyloid-positive participants, while occipital lobe
ROIs had a lower prevalence (Figure 2,3). Subcortical ROIs provided
inconsistent evidence of bimodal distributions. Across the various
pipelines, agreement with regard to amyloid positivity was high, with a
Fleiss Kappa score over all 144 different SUVR measures being 0.714.
The results from all the different pipelines have been combined and
standardized against the amyloid negative distribution for comparison in
Figure 3.
Figure 2 Regional variability of SUVR cutpoints, using the whole 
cerebellum as a reference, pesudoCT attenuation correction and 
no volume correction 
Figure 3 Comparison across all SUVR measures. All measures are standardized to create z-scores which are based on 
the amyloid negative distribution from the Gaussian mixture model, with the 99th percentile (Z=2.33) corresponding to 
the cutpoint. Each row represents the SUVR measures for a single individual. Each column represents a different SUVR 
measure, grouped first by ROI, then attenuation correction method, partial volume correction and reference ROI. 
Key: CGM=cortical GM, Fr=Frontal Lobe, Tmp=Temporal Lobe, Prtl=Parietal Lobe, PrC=precuneus, A/MC=Anterior and 
















pCT, no PVC 0.959 (0.053) 1.218 (0.100) 1.080 17.5%
UTE, no PVC 0.996 (0.054) 1.255 (0.106) 1.120 18.5%
pCT, with PVC 0.759 (0.059) 1.129 (0.183) 0.899 23.3%
UTE, with PVC 0.784 (0.063) 1.153 (0.190) 0.917 24.5%
Cerebellar 
Grey Matter
pCT, no PVC 1.103 (0.077) 1.424 (0.113) 1.275 15.4%
UTE, no PVC 1.156 (0.077) 1.485 (0.113) 1.326 14.7%
pCT, with PVC 1.019 (0.109) 1.581 (0.267) 1.253 20.4%
UTE, with PVC 1.053 (0.106) 1.574 (0.269) 1.260 24.1%
Pons
pCT, no PVC 0.575 (0.040) 0.754 (0.066) 0.664 15.8%
UTE, no PVC 0.557 (0.037) 0.729 (0.058) 0.641 17.6%
pCT, with PVC 0.462 (0.049) 0.729 (0.118) 0.574 18.8%




pCT, no PVC 0.541 (0.036) 0.688 (0.053) 0.621 17.5%
UTE, no PVC 0.535 (0.035) 0.677 (0.049) 0.611 16.8%
pCT, with PVC 0.444 (0.055) 0.705 (0.105) 0.565 17.8%
UTE, with PVC 0.438 (0.050) 0.694 (0.120) 0.548 19.4%
Table The effects of reference region, partial volume correction, and attenuation correction on the 
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Cortical GM SUVR distribution and Model Fits
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BACKGROUND
Amyloid-specific PET tracers provide quantitative measurements of
amyloid load in vivo. These measurements may help identify asymptomatic
individuals at an early stage of Alzheimer’s disease. Quantitative measures
of amyloid deposition are often dichotomised into positive and negative
groups through cutpoints. When these are based on post-mortem
pathology, they are highly specific, but may not be sensitive to the initial
signs of amyloid deposition[1]. These methods are also highly dependent
on numerous analytical choices[2], such as the region of interest (ROI),
reference ROI, partial volume correction, and statistical criteria for
choosing the cutpoint[3].
PET-MR scanners are now commercially available; while they provide
simultaneous, co-aligned acquisition of these modalities and may also
reduce patient burden and radioactive dose, these these scanners present
methodological challenges for important reconstruction steps like
attenuation correction. We examined these aspects on quantifying amyloid
burden using a PET-MR scanner using a large UK sample of individuals
born in the same week in 1946.
METHODS
Subjects The first 250 participants enrolled in Insight 46, a neuroimaging
sub-study of 500 individuals from the MRC National Survey of Health and
Development (NSHD)[4].
Image acquisition and processing All data were acquired on a Siemens
Biograph PET-MR scanner
Volumetric T1-weighted data acquired at 1.1 mm isotropic resolution was
parcellated into anatomical ROIs [5].
18F-florbetapir Amyloid PET mages were reconstructed from list mode data
acquired 50-60 minutes post-injection. Two methods of attenuation correction
were used: an ultrashort echo time (UTE) MR sequence and a pseudo CT (pCT)
method[6].
PET and MRI data were co-registered to provide anatomical ROIs in PET space.
For multiple ROIs, standard uptake value ratios (SUVR) were computed using four
reference regions: whole cerebellum (WCB), cerebellar grey matter (CGM), pons,
and subcortical white matter (SCWM).
Data were processed both with no partial volume correction and with the Iterative
Yang technique [7] on PET data resampled into T1 space, using an isotropic
kernel of 6.8mm and ten iterations.
Cut point definition: Data were fitted with a Gaussian mixture model, using one to
three clusters, choosing the best fit according to Bayes Information Criteria. The
cutpoint was defined as the 99th percentile of the amyloid negative distribution
(Figure 1).
Figure 1 Histogram of SUVR
values (cortical grey matter
ROI, whole cerebellum
reference ROI) from the 240
included participants. The
Gaussian mixture model is
overlaid on top of the
histogram, showing the good fit,
particularly of the amyloid
negative distribution.
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